Precision Transcranial Magnetic Stimulation for Patients With Post-stress Sleep Disorders

Launched by XIJING HOSPITAL · Oct 21, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at a treatment called transcranial magnetic stimulation (TMS) to help people who have trouble sleeping after experiencing a stressful event, like a traumatic experience. TMS is a non-invasive therapy that uses magnetic fields to stimulate nerve cells in the brain. The study aims to see if this personalized treatment can improve sleep for those struggling with insomnia related to stress.

To be eligible for this trial, you need to be between 18 and 60 years old and have experienced a severe traumatic event. You should also score above certain thresholds on specific questionnaires that measure stress and sleep quality. Participants will receive individualized TMS therapy and will be closely monitored throughout the study. It’s important to note that those with certain medical conditions or who are currently receiving other types of therapy may not be eligible to participate. If you think you might qualify and are interested in helping researchers understand how TMS can aid in sleep disorders caused by stress, this could be a valuable opportunity.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Be between the ages of 18 and 60 (both 18 and 60) and of any gender;
• • 2. Experienced a severe traumatic event;
• • 3. Stanford Acute Stress Reaction Questionnaire (SASRQ) ≥40 points;
• • 4. PSQI \> 7 points;
• • 5. Good compliance and willingness to undergo this therapy.
• Exclusion Criteria:
• • 1. Sleep disorders that can be explained by a primary illness;
• • 2. Concurrent psychotherapy;
• • 3. Those with contraindications to magnetic resonance examination and transcranial magnetic stimulation therapy;
• • 4. Combined with serious cardiovascular, hepatic, renal, digestive, hematopoietic system and other primary diseases.